Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients
Status:
Recruiting
Trial end date:
2021-10-30
Target enrollment:
Participant gender:
Summary
To measure the effect of Ivermectin (sub-cutaneous) with or without zinc in treating the
COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of
symptoms and length of hospitalization of patients with COVID-19.